Valuation: AtriCure, Inc.

Market Cap 2.25B 1.95B 1.83B 1.66B 3.13B 215B 3.18B 21.43B 8.38B 108B 8.46B 8.28B 359B P/E 2026 *
420x
P/E 2027 * 106x
Enterprise Value 2.1B 1.81B 1.71B 1.55B 2.92B 201B 2.96B 19.98B 7.81B 101B 7.89B 7.72B 334B EV / Sales 2026 *
3.47x
EV / Sales 2027 * 2.98x
Free-Float
96.19%
Yield 2026 *
-
Yield 2027 * -
1 day+2.00%
1 week+7.18%
Current month+17.48%
1 month+29.25%
3 months+57.58%
6 months+35.87%
Current year+12.13%
1 week 41.01
Extreme 41.01
44.48
1 month 31.9
Extreme 31.895
44.48
Current year 25.36
Extreme 25.36
44.48
1 year 25.36
Extreme 25.36
44.48
3 years 18.94
Extreme 18.94
52.12
5 years 18.94
Extreme 18.94
89.18
10 years 14.36
Extreme 14.355
89.18
Manager TitleAgeSince
Chief Executive Officer 55 01/11/2012
Director of Finance/CFO 48 30/06/2014
Chief Tech/Sci/R&D Officer 59 17/07/2017
Director TitleAgeSince
Director/Board Member 55 01/11/2012
Director/Board Member 64 10/03/2013
Director/Board Member 75 09/11/2016
Date Insider Type Main position Quantity % Market Cap.
05/08/26 Sell

Director

-3,500 0.0069%
05/08/26 Sell

Director

-3,564 0.0070%
30/07/26 Don

Chief Executive Officer

-4,700 0.0092%
Change 5-day change 1-year change 3-year change Capi.($)
+2.00%+7.18%+25.28%-14.16% 2.25B
-0.02%+3.19%-13.95%+4.85% 193B
+0.76%+4.72%-0.77%+9.75% 117B
+1.43%-2.07%+6.43%+67.25% 59.89B
+0.32%+3.92%+38.42%+65.14% 56.01B
+0.79%+3.70%-5.95%-35.11% 49.96B
-1.89%+5.90%+12.24%-22.47% 33.87B
+0.45%+1.45% - - 31.36B
+0.94%-1.31%+41.93%-12.62% 24.59B
+1.98%+12.62%-2.80%+25.91% 24.77B
Average +0.68%+4.04%+11.20%+9.84% 59.2B
Weighted average by Cap. +0.43%+3.42%+1.60%+13.44%

Financials

2026 *2027 *
Net sales 606M 524M 492M 447M 841M 57.97B 855M 5.77B 2.25B 29.03B 2.28B 2.23B 96.47B 680M 587M 552M 502M 943M 64.99B 959M 6.46B 2.53B 32.54B 2.55B 2.5B 108B
Net income 7.11M 6.14M 5.77M 5.25M 9.87M 680M 10.03M 67.64M 26.45M 341M 26.7M 26.12M 1.13B 20.78M 17.94M 16.86M 15.34M 28.83M 1.99B 29.31M 198M 77.25M 995M 78.01M 76.31M 3.31B
Net Debt -152M -131M -123M -112M -211M -14.55B -215M -1.45B -566M -7.28B -571M -559M -24.21B -226M -195M -184M -167M -314M -21.64B -319M -2.15B -841M -10.84B -850M -831M -36.01B
Logo AtriCure, Inc.
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Employees
1,350
Date Price Change Volume
14/08/26 US$44.30 +1.86% 340,912
13/08/26 US$43.49 -0.16% 549,782
12/08/26 US$43.56 +1.42% 473,251
11/08/26 US$42.95 +3.15% 562,463
10/08/26 US$41.64 +0.60% 529,526
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
44.30USD
Average target price
47.33USD
Spread / Average Target
+6.85%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ATRC Stock